Reinsurance articles

Silent technology exposure in legacy wordings needs a leadership decision on sequencing and priority, not just a legal review buried inside the wording team's backlog.

2026-09-09

Silent technology exposure in legacy wordings does not just create claims disputes, it quietly caps how much profitable new business a reinsurer can safely write.

2026-09-09

Anti-selection in digital life distribution needs a concrete operating process in life and health reinsurance, not just policy statements. Here is what that process actually looks like.

2026-09-08

Anti-selection in digital life distribution is becoming a real executive risk in life and health reinsurance as accelerated underwriting scales faster than fraud controls. Here is how the problem starts.

2026-09-08

Anti-selection in digital life distribution deserves direct board scrutiny in life and health reinsurance. Here is how boards should evaluate whether this risk is genuinely under control.

2026-09-08

Anti-selection in digital life distribution needs a clear executive decision framework in life and health reinsurance. Here is how CUOs should think about the tradeoff between speed and verification.

2026-09-08

Anti-selection in digital life distribution erodes return on capital in life and health reinsurance well before it shows up as an obvious claims spike. Here is how the erosion actually happens.

2026-09-08

Behavioral lapse models that fail in stress need specific, repeatable operating controls, not just a stronger model, to catch drift early and keep pricing and reserving aligned with real experience.

2026-09-08

The P&L impact of behavioral lapse models that fail in stress is easy to underestimate because it moves through reserves, DAC amortization, and capital charges before it ever reaches the headline numbers.

2026-09-08

Boards overseeing life and health reinsurers need specific, evidence-based questions to confirm management actually controls behavioral lapse models that fail in stress, not just assurances that it does.

2026-09-08

Behavioral lapse models that fail in stress cut across underwriting, finance, claims, and risk, and an unclear ownership structure is often the real reason the failure goes uncorrected for so long.

2026-09-08

Behavioral lapse models that fail in stress are not a modeling footnote, they are a direct earnings and capital problem for life and health reinsurers. Here is why the failure happens and what it costs.

2026-09-08

Biometric risk correlation after population events needs a clear data-ownership and escalation model. Here is how reinsurers should structure ongoing monitoring for this exposure.

2026-09-08

Biometric risk correlation after population events is the diagnosis problem growing quietly behind biometric-informed reinsurance portfolios. Here is why individually strong risk signals can become correlated portfolio risk overnight.

2026-09-08

Biometric risk correlation after population events does not erode margin gradually the way isolated mispricing does. Here is why it hits a reinsurance portfolio all at once, and how to size that exposure.

2026-09-08

Biometric risk correlation after population events raises a direct balance-sheet question boards are not yet asking. Here is how much exposure it can create, and how to size it.

2026-09-08

Biometric risk correlation after population events raises questions most vendor pricing models have never had to answer. Here is the executive decision framework a Chief Actuary should apply.

2026-09-08

Claims leakage in high-volume health portfolios stops being a recurring surprise once it becomes a measured, repeatable process with clear metrics, sampling standards, and accountability.

2026-09-08